Team:British Columbia/Human Practices

From 2012.igem.org

(Difference between revisions)
m
Line 1: Line 1:
{{Template:Team:British_Columbia_Header}}
{{Template:Team:British_Columbia_Header}}
 +
 +
==Intellectual Property==
==Intellectual Property==
Line 6: Line 8:
*[http://biobricks.org/bpa/faq/ biobrick agreement]
*[http://biobricks.org/bpa/faq/ biobrick agreement]
*[https://2011.igem.org/Team:UQ-Australia/Human_Practices]
*[https://2011.igem.org/Team:UQ-Australia/Human_Practices]
 +
===Survey questions for iGEM===
 +
Blurb about IP & patents.
 +
* What experiences have you had with IP in iGEM?
 +
** How did you approach the process?
 +
** What resources did you use?  Do you know how to find resources?
 +
** What issues did you encounter?
 +
** Have you consulted anyone outside of your team about IP?
 +
** What would you like to have done to improve your experience?
 +
** Do you have experience outside of iGEM?
 +
* Has IP concerns affected your project? If so, how?
 +
* What do you want to know about IP that we can help you with?
 +
* Are you worried about the IP aspect of your project?
 +
* Would you be interested in a FAQ about IP for iGEM?
 +
** What type of format would you prefer?  (e.g., video, FAQ page, "Choose your own adventure" walkthrough, etc.)
 +
* Are you interested in protecting our own IP (e.g., through patenting)?
 +
* Do you think Biobricks can be patented?
 +
* Do you think iGEM teams can produce patentable projects?
 +
* Do you think you can take your patent country to country easily?
 +
* How much do you think patenting something costs?
 +
* How much time do you think the patenting process would take?
 +
* What is your main IP concern: Use of existing patents or establishing ownership of new patents?
 +
* Do you know if your team's project depends on anything that is protected by IP rights?
 +
** Do you think this would get in the way for patenting your own project?
 +
* What aspect of dealing with IP would you like the most help with?  What would you like to get out of a FAQ?
 +
* How do you think IP protection affects innovation?
 +
** Do you think IP protection and open source ideals can coexist?
 +
* How does IP help/hurt your project?
 +
===Questions for Professionals===
 +
* What's a good rule of thumb for determining what things in biotechnology be patentable?
 +
** Does that strongly vary among jurisdiction?
 +
* What are particularly difficult jurisdictions to get patents in?
 +
* What pitfalls might an iGEM team run into?
 +
* Do you think it's worthwhile for iGEM teams to explore patenting for their projects? (ask Randy Retberg/iGEM HQ too)
 +
* How do you think IP protection affects innovation?
 +
* Is it generally worth getting a patent in just one country?
 +
* How does the industry approach/handle patents held by researchers? 
 +
* How does IP help/hurt your project?
 +
* How do you decide if something is worth patenting/licensing?
 +
* What are the university's policies concerning ownership of researchers' work?  How are they generally compared to other universities?
 +
* How does the UILO/TTO help researchers reach their goals in getting IP protection?
 +
* What happens when someone infringes a patent?
 +
* What happens when someone doesn't give the university ownership of the IP?  For example, if the researcher claims that he/she worked on it on their own time or at another institution?
 +
* How does company sponsorship affect IP ownership?
 +
* What are some typical problems researchers encounter?
 +
==Community Outreach==
==Community Outreach==

Revision as of 01:46, 28 June 2012

British Columbia - 2012.igem.org


Contents

Intellectual Property

Survey questions for iGEM

Blurb about IP & patents.

  • What experiences have you had with IP in iGEM?
    • How did you approach the process?
    • What resources did you use? Do you know how to find resources?
    • What issues did you encounter?
    • Have you consulted anyone outside of your team about IP?
    • What would you like to have done to improve your experience?
    • Do you have experience outside of iGEM?
  • Has IP concerns affected your project? If so, how?
  • What do you want to know about IP that we can help you with?
  • Are you worried about the IP aspect of your project?
  • Would you be interested in a FAQ about IP for iGEM?
    • What type of format would you prefer? (e.g., video, FAQ page, "Choose your own adventure" walkthrough, etc.)
  • Are you interested in protecting our own IP (e.g., through patenting)?
  • Do you think Biobricks can be patented?
  • Do you think iGEM teams can produce patentable projects?
  • Do you think you can take your patent country to country easily?
  • How much do you think patenting something costs?
  • How much time do you think the patenting process would take?
  • What is your main IP concern: Use of existing patents or establishing ownership of new patents?
  • Do you know if your team's project depends on anything that is protected by IP rights?
    • Do you think this would get in the way for patenting your own project?
  • What aspect of dealing with IP would you like the most help with? What would you like to get out of a FAQ?
  • How do you think IP protection affects innovation?
    • Do you think IP protection and open source ideals can coexist?
  • How does IP help/hurt your project?

Questions for Professionals

  • What's a good rule of thumb for determining what things in biotechnology be patentable?
    • Does that strongly vary among jurisdiction?
  • What are particularly difficult jurisdictions to get patents in?
  • What pitfalls might an iGEM team run into?
  • Do you think it's worthwhile for iGEM teams to explore patenting for their projects? (ask Randy Retberg/iGEM HQ too)
  • How do you think IP protection affects innovation?
  • Is it generally worth getting a patent in just one country?
  • How does the industry approach/handle patents held by researchers?
  • How does IP help/hurt your project?
  • How do you decide if something is worth patenting/licensing?
  • What are the university's policies concerning ownership of researchers' work? How are they generally compared to other universities?
  • How does the UILO/TTO help researchers reach their goals in getting IP protection?
  • What happens when someone infringes a patent?
  • What happens when someone doesn't give the university ownership of the IP? For example, if the researcher claims that he/she worked on it on their own time or at another institution?
  • How does company sponsorship affect IP ownership?
  • What are some typical problems researchers encounter?


Community Outreach

US/Canada Regulatory Concerns

  • illegitimate DNA transfer (strains on band-aids in magazines?)

OSLI feedback

  • Biosafety
  • Efficiency
  • Environmental
Retrieved from "http://2012.igem.org/Team:British_Columbia/Human_Practices"